Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

State Street SPDR S&P Biotech ETF (NY:XBI)

124.98 -1.32 (-1.05%)

Official Closing Price Updated: 8:00 PM EST, Dec 26, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	5,653,939
Open	125.89
Bid (Size)	124.91 (2,000)
Ask (Size)	124.98 (500)
Prev. Close	126.30
Today's Range	124.18 - 126.00
52wk Range	66.66 - 126.50
Shares Outstanding	541,500
Dividend Yield	0.09%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Healthcare Sector Falters: S&P 500's Biggest Loser Amid Broader Market Caution

December 09, 2025

New York, NY – December 9, 2025 – The S&P 500 Healthcare sector found itself in a precarious position today, emerging as the biggest underperformer among its peers. While the broader S&P 500 index...

Via MarketMinute

Eaton, FTAI Aviation And More On CNBC's 'Final Trades' ↗

November 28, 2025

FTAI Aviation (NASDAQ: FTAI) is recommended by investment experts to diversify portfolios beyond tech, while Eaton (NYSE: ETN) and SPDR S&P Biotech ETF (NYSE: XBI) show promising price action. SoFi's...

Via Benzinga

Performance

YTD	+36.5%	+36.5%
1 Month	+1.5%	+1.5%
3 Month	+25.7%	+25.7%
6 Month	+50.7%	+50.7%
1 Year	+36.8%	+36.8%

More News

Biotech Insiders Are Spending Billions. Trump Favors Less Oversight. One Biotech ETF Could Ride the Surge. ↗

November 17, 2025

Via The Motley Fool

Cidara Therapeutics Granted FDA Breakthrough Therapy Designation For Flu-Preventing Antiviral ↗

October 09, 2025

Via Stocktwits

White House Clarifies Recent Pharmaceutical Tariffs Exempt Countries with Trade Agreements: Report ↗

September 26, 2025

Via Stocktwits

Money Moving Into Healthcare Not AI; Four Fed Presidents Do Not Want a Rate Cut; Euphoria Wearing Off ↗

November 13, 2025

Via Benzinga

Taiwan Semiconductor, HealthEquity, Cboe Global Markets And More: CNBC's 'Final Trades' ↗

November 13, 2025

Via Benzinga

Biotech ETFs Come Alive As Illumina Soars 23% — Is The Genomics Winter Finally Over? ↗

November 03, 2025

Via Benzinga

FDA Turmoil Spills Over To Aurinia Pharma As Lawsuit Targets Ex-Drug Review Chief — Retail Traders Cry ‘Stock Manipulation’ ↗

November 02, 2025

Via Stocktwits

Top 6 ETFs To Watch As Wall Street's Strongest Six Months Begin ↗

October 30, 2025

Via Benzinga

Intellia Freezes Key Trial After Serious Liver Event, Stock Tumbles ↗

October 27, 2025

Via Benzinga

Why Avidity Biosciences Stock Is Jumping Over 43% In Premarket Today ↗

October 27, 2025

Via Stocktwits

Biotech Boom: Strategic Realignments and AI Integration Fuel Investor Focus, Signaling Broader Market Shifts

October 19, 2025

Via MarketMinute

SciSparc Expands Biotech Ambitions, Buys Stake In Miza III Ventures ↗

October 15, 2025

Via Benzinga

4 Biotech Stocks Seeing Explosive Momentum Gains ↗

October 07, 2025

Via Benzinga

How Trump's Shutdown Standoff Could Hand Health-Care ETFs A Lifeline ↗

October 07, 2025

Via Benzinga

SciSparc And AutoMax Call Off Merger ↗

October 06, 2025

Via Benzinga

Eli Lilly Stock Jumps As Trump’s Drug Price Crackdown Spurs Sector Rally; Analysts Say Pfizer Deal Sets Template For Big Pharma ↗

September 30, 2025

Via Stocktwits

Pharma Tariffs Back In Spotlight On New Trump Threat ↗

September 26, 2025

Via Investor's Business Daily

Trump Shocks Pharma With 100% Tariff On Imported Drugs Unless Companies Build In America ↗

September 25, 2025

Via Stocktwits

uniQure Stock Rises Pre-Market After Investigational Huntington’s Disease Drug Slows Disease In Trial ↗

September 24, 2025

Via Stocktwits

CrowdStrike, SoFi, Clearway Energy And More: CNBC's 'Final Trades' ↗

September 19, 2025

Via Benzinga

As the Fed Pivots, These 3 ETFs Are Positioned to Outperform ↗

September 11, 2025

Via The Motley Fool

Trump's Biotech Playbook Ignites $350 Billion Investment Blitz ↗

September 09, 2025

Via Benzinga

Drug Tariffs Finally Land. Why Pharma Stocks Are Breathing Easy. ↗

August 22, 2025

Via Investor's Business Daily

Frequently Asked Questions

Is State Street SPDR S&P Biotech ETF publicly traded?

Yes, State Street SPDR S&P Biotech ETF is publicly traded.

What exchange does State Street SPDR S&P Biotech ETF trade on?

State Street SPDR S&P Biotech ETF trades on the New York Stock Exchange

What is the ticker symbol for State Street SPDR S&P Biotech ETF?

The ticker symbol for State Street SPDR S&P Biotech ETF is XBI on the New York Stock Exchange

What is the current price of State Street SPDR S&P Biotech ETF?

The current price of State Street SPDR S&P Biotech ETF is 124.98

When was State Street SPDR S&P Biotech ETF last traded?

The last trade of State Street SPDR S&P Biotech ETF was at 12/26/25 08:00 PM ET

What is the market capitalization of State Street SPDR S&P Biotech ETF?

The market capitalization of State Street SPDR S&P Biotech ETF is 67.68M

How many shares of State Street SPDR S&P Biotech ETF are outstanding?

State Street SPDR S&P Biotech ETF has 68M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.